Results 281 to 290 of about 53,729,253 (423)

Relationship Factors in Treating Substance Use Disorders [PDF]

, 2005
Kelly, John, Knobloch-Fedders, Lynne M., Lebow, Jay L., Moos, Rudolf   +3 more
core   +1 more source

Correction: Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply

Harm Reduction Journal
Bruce Wallace, Irene Shkolnikov, Collin Kielty, Derek Robinson, Lea Gozdzialski, Joshua Jai, Ava Margolese, Pablo Gonzalez-Nieto, Armin Saatchi, Lucas Abruzzi, Taelor Zarkovic, Chris Gill, Dennis Hore   +12 more
doaj   +1 more source

Substance use among Ghanaian adolescents in secondary education: the determinants and medico-social implications. [PDF]

BMC Public Health
Appati W, Otupiri E, Appati A, Ntim EBO.
europepmc   +1 more source

Substance use in a school-based clinic population: Use of the randomized response technique to estimate prevalence

, 1992
Martin Fisher, Linda B. Kupferman, Martin Lesser   +2 more
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

The Use and Physical Effects of Intravaginal Substances in Zairian Women

, 1993
Richard C. D. Brown, Judith Brown, Okako Bibi Ayowa   +2 more
openalex   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

Molecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben‐Moshe, Anya Pavlovsky, Rinat Bernstein‐Molho, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal‐Yam   +14 more
wiley   +1 more source

Clients' Experiences and Satisfaction with an Integrated Intensive Outpatient Program for Substance Use Disorders. [PDF]

Actas Esp Psiquiatr
Bador K, Johansson C, Axelsson I, Nilsson M, Kerekes N.   +4 more
europepmc   +1 more source

Predictors of shelter use among low-income families: psychiatric history, substance abuse, and victimization.

, 1992
Beth C. Weitzman, James R. Knickman, Marybeth Shinn   +2 more
openalex   +2 more sources

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source